- Filed
- Nov 3, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 21, 2025 | 521.18K sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $2.1K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $4.27K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $25.47K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $9.33M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.92M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $10.06M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $9.93M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $339.74K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $378.33K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.05M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.38M |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.88 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$2.02 |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 471.4K sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$436.76K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$7.68M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$6.86M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$2.02 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $531.65K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$953.97K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$426.97K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $797.79K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $966.21K |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.76M |